Clinical Trials Logo

Aortic Aneurysm clinical trials

View clinical trials related to Aortic Aneurysm.

Filter by:

NCT ID: NCT02266342 Completed - Aortic Diseases Clinical Trials

GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry

Start date: October 2014
Phase:
Study type: Observational [Patient Registry]

This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® TAG® Thoracic Endoprosthesis treating diseases of the thoracic aorta.

NCT ID: NCT02256163 Completed - Clinical trials for Thoracic Aortic Aneurysm

Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm

TAA
Start date: June 2011
Phase: N/A
Study type: Observational

The primary objectives of the study are - to assess the contribution of alteration of each known gene on non-syndromic TAA. - to map and identify unknown gene involved in the non-syndromic TAA.

NCT ID: NCT02253082 Completed - Clinical trials for Endothelial Dysfunction

Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)

VIPER-OCTA
Start date: November 2014
Phase: Phase 4
Study type: Interventional

Effects of OctaplasLG® on endothelial integrity in patients undergoing emergency surgery for thoracic aortic dissections - a randomized, controlled, single-blinded investigator-initiated pilot trial

NCT ID: NCT02236923 Completed - Aortic Aneurysm Clinical Trials

Study of the Influence of the Moon and Seasons On Outcomes Following Surgery To Repair Ascending Aortic Dissection

ACS-MOON-1
Start date: January 1998
Phase: N/A
Study type: Observational

That the full-moon stage of the lunar cycle is associated with reduced mortality and shorter length of stay in patients undergoing repair of aortic dissection, after adjusting for seasonal effects, demographics and cardiovascular risk factors.

NCT ID: NCT02229006 Completed - Clinical trials for Abdominal Aortic Aneurysm

Sodium Fluoride Imaging of Abdominal Aortic Aneurysms

SoFIA3
Start date: September 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether Sodium Fluoride imaging (using Positron Emission Tomography-Computed Tomography - PET-CT) is able to help predict the rate of abdominal aortic aneurysm expansion.

NCT ID: NCT02224794 Completed - Clinical trials for Abdominal Aortic Aneurysm

LIFE Study: Least Invasive Fast-Track EVAR

Start date: September 2014
Phase:
Study type: Observational [Patient Registry]

The primary objectives of the LIFE Study are to demonstrate the clinical and cost benefits associated with using the Ovation® Abdominal Stent Graft Platform under the least invasive conditions defined in the Fast-Track EVAR protocol. The key elements of the Fast-Track EVAR protocol include: appropriate patient selection, bilateral percutaneous access, no general anesthesia, no ICU admission post procedure, and next day discharge.

NCT ID: NCT02213484 Completed - Turner Syndrome Clinical Trials

Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes

Start date: July 1, 2014
Phase: N/A
Study type: Observational

The primary objective of this study is to determine whether specific patterns of circulating micro-ribonucleic acids (miRNAs) are associated with aortic aneurysm and dissection in patients with hereditary aortopathy syndromes. The most common of these syndromes is Marfan Syndrome (MFS), but several other recognized aortopathy syndromes are well characterized. The investigators propose the use of a simple blood test, from which miRNA profiles can be measured in individuals with aortopathy syndromes to be compared with miRNAs observed in a control population that has no known predisposition for aortic disease. The investigators hypothesize that microRNA profiles in individuals with Marfan syndrome, and related disorders, will be distinct from those seen in a control group. The investigators predict that up- or down-regulation of certain miRNAs will correlate with the presence and severity of aortic aneurysm, responses to medical therapy, and ultimately could be used to determine when an individual may be at risk of dissection.

NCT ID: NCT02204774 Completed - Clinical trials for Obstructive Sleep Apnea

Is Obstructive Sleep Apnoea a Risk Factor for Thoracic Aortic Aneurysm Expansion? A Prospective Cohort Study.

Start date: July 5, 2014
Phase:
Study type: Observational

The objective of this prospective cohort study in patients with a known thoracic aortic aneurysm is to test the hypothesis that yearly aneurysm progression rate is higher in patients with obstructive sleep apnoea (OSA) compared to patients without OSA, and that the need for aortic operation or proven or presumed death from aortic rupture or dissection happens more often in patients with thoracic aortic aneurysm and OSA compared to patients without OSA.

NCT ID: NCT02176174 Completed - Stroke Clinical Trials

Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study

Start date: December 2013
Phase: N/A
Study type: Observational

Specific cardiovascular diseases, such as stroke and heart attack, have been shown to vary by ethnic group. However, less is known about differences between ethnic groups and a wider range of cardiovascular diseases. This study will examine differences between ethnic groups (White, Black, South Asian and Mixed/Other) and first lifetime presentation of twelve different cardiovascular diseases. This information may help to predict the onset of cardiovascular diseases and inform disease prevention strategies. The hypothesis is that different ethnic groups have differing associations with the range of cardiovascular diseases studied.

NCT ID: NCT02164201 Completed - Clinical trials for Thoracic Aortic Aneurysm

Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery

Start date: August 2014
Phase: N/A
Study type: Observational

This is a prospective, multicenter, single-arm study designed to collect clinical data to support the safety and effectiveness of BioFoam used as a surgical adjunct to anastomotic hemostasis following cardiovascular surgery. The overall objective of this clinical study is to collect clinical data supporting the safety and effectiveness of BioFoam used as a surgical adjunct to anastomotic hemostasis following cardiovascular surgery. This study is intended as a post-market surveillance (follow-up) study.